Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha
A cyclooxygenase-2 (COX-2) inhibitor celecoxib has been previously reported to have cytotoxic activities towards gastric, prostate, ovarian, colon and breast cancer cell lines. This article reports that the cytotoxic activities of celecoxib could be resulted from its activity as a potent ligand for...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Gadjah Mada
2015-11-01
|
Series: | Indonesian Journal of Chemistry |
Subjects: | |
Online Access: | https://jurnal.ugm.ac.id/ijc/article/view/21196 |
id |
doaj-41610ca744ac439ba24c2964253b7976 |
---|---|
record_format |
Article |
spelling |
doaj-41610ca744ac439ba24c2964253b79762020-11-25T01:27:42ZengUniversitas Gadjah MadaIndonesian Journal of Chemistry1411-94202460-15782015-11-0115327428010.22146/ijc.2119614294Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor AlphaEnade Perdana Istyastono0Florentinus Dika Octa Riswanto1Sri Hartati Yuliani2Division of Drug Design and Discovery, Faculty of Pharmacy, Sanata Dharma University, Paingan, Maguwohardjo, Depok, Yogyakarta 55282Division of Food and Drug Safety, Quality and Efficacy, Faculty of Pharmacy, Sanata Dharma University, Paingan, Maguwohardjo, Depok, Yogyakarta 55282Division of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Sanata Dharma University, Paingan, Maguwohardjo, Depok, Yogyakarta 55282A cyclooxygenase-2 (COX-2) inhibitor celecoxib has been previously reported to have cytotoxic activities towards gastric, prostate, ovarian, colon and breast cancer cell lines. This article reports that the cytotoxic activities of celecoxib could be resulted from its activity as a potent ligand for estrogen receptor alpha (ERα). Aided by molecular docking simulations, an in silico test to examine whether celecoxib is a ligand for estrogen receptor alpha (ERα) was performed followed by in vitro test employing cytotoxic assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method. The compound was extracted from Celebrex®. Measured by using UV spectrophotometric method at 255.5 nm, it was identified that the content of celecoxib was 102.15 mg/271.48 mg capsule content. The in silico test indicated that celecoxib is a potent ligand for ERα. This finding was confirmed experimentally by an in vitro test that celecoxib has a comparable activity as an ERα ligand to tamoxifen, a drug of choice for breast cancer treatment.https://jurnal.ugm.ac.id/ijc/article/view/21196cyclooxygenase-2estrogen receptor alphamolecular dockingcelecoxib |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Enade Perdana Istyastono Florentinus Dika Octa Riswanto Sri Hartati Yuliani |
spellingShingle |
Enade Perdana Istyastono Florentinus Dika Octa Riswanto Sri Hartati Yuliani Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha Indonesian Journal of Chemistry cyclooxygenase-2 estrogen receptor alpha molecular docking celecoxib |
author_facet |
Enade Perdana Istyastono Florentinus Dika Octa Riswanto Sri Hartati Yuliani |
author_sort |
Enade Perdana Istyastono |
title |
Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha |
title_short |
Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha |
title_full |
Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha |
title_fullStr |
Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha |
title_full_unstemmed |
Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha |
title_sort |
computer-aided drug repurposing: a cyclooxygenase-2 inhibitor celecoxib as a ligand for estrogen receptor alpha |
publisher |
Universitas Gadjah Mada |
series |
Indonesian Journal of Chemistry |
issn |
1411-9420 2460-1578 |
publishDate |
2015-11-01 |
description |
A cyclooxygenase-2 (COX-2) inhibitor celecoxib has been previously reported to have cytotoxic activities towards gastric, prostate, ovarian, colon and breast cancer cell lines. This article reports that the cytotoxic activities of celecoxib could be resulted from its activity as a potent ligand for estrogen receptor alpha (ERα). Aided by molecular docking simulations, an in silico test to examine whether celecoxib is a ligand for estrogen receptor alpha (ERα) was performed followed by in vitro test employing cytotoxic assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method. The compound was extracted from Celebrex®. Measured by using UV spectrophotometric method at 255.5 nm, it was identified that the content of celecoxib was 102.15 mg/271.48 mg capsule content. The in silico test indicated that celecoxib is a potent ligand for ERα. This finding was confirmed experimentally by an in vitro test that celecoxib has a comparable activity as an ERα ligand to tamoxifen, a drug of choice for breast cancer treatment. |
topic |
cyclooxygenase-2 estrogen receptor alpha molecular docking celecoxib |
url |
https://jurnal.ugm.ac.id/ijc/article/view/21196 |
work_keys_str_mv |
AT enadeperdanaistyastono computeraideddrugrepurposingacyclooxygenase2inhibitorcelecoxibasaligandforestrogenreceptoralpha AT florentinusdikaoctariswanto computeraideddrugrepurposingacyclooxygenase2inhibitorcelecoxibasaligandforestrogenreceptoralpha AT srihartatiyuliani computeraideddrugrepurposingacyclooxygenase2inhibitorcelecoxibasaligandforestrogenreceptoralpha |
_version_ |
1715764520579760128 |